MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Effects of a nurse-led Advance Care Planning and Care Coordination intervention in Parkinson’s Disease – patient and family caregiver perspectives from a multicentre European study

    C. Muente, BW. Dijkstra, CM. Groot, MJ. Meinders (Nijmegen, Netherlands)

    Objective: To investigate an Advance Care Planning (ACP) and care coordination intervention from the perspective of people with Parkinson's disease (PwPD) and their family caregivers…
  • 2023 International Congress

    Transcriptional dysregulation in iPSC-derived neurons from patients with X-linked dystonia-parkinsonism

    K. Grütz, A. Künstner, C. Klein, H. Busch, P. Seibler (Lübeck, Germany)

    Objective: We pursue to identify dysregulated cellular pathways underlying X-linked dystonia-parkinsonism (XDP) by transcriptome profiling of induced pluripotent stem cell (iPSC)-derived neuronal cultures from XDP…
  • 2023 International Congress

    Microbiota and Gastrointestinal Manifestations of Parkinson’s Disease with Arabic Translation of Gastrointestinal Dysfunction Scale

    Y. Salah, N. Dawood, M. Salama, A. Shalash (cairo, Egypt)

    Objective: To investigate the frequency of occurrence of gastrointestinal tract GIT symptoms and their relation to patients’ clinical characteristics in addition the characteristics of gut…
  • 2023 International Congress

    Exploring brain mechanisms of identity attribution in presence hallucinations of Parkinsonian origin

    J. Potheegadoo, N. Vehar, F. Bernasconi, C. Stucker, S. Stampacchia, O. Blanke (Geneva, Switzerland)

    Objective: Study cognitive, behavioral correlates of identity of presence hallucinations in Parkinson’s disease. Background: Presence hallucination (PH), the sensation that someone is nearby when no…
  • 2023 International Congress

    Effect of variants in COMT and UGT1A genes on clinical response in patients with Parkinson’s disease treated with opicapone

    E. Ojeda-Lepe, S. García-Díaz, R. Díaz Belloso, L. Muñoz-Delgado, S. Jesús, MT. Periñán, B. Benítez Zamora, AD. Adarmes-Gómez, D. Macías-García, M. Martín-Bornez, M. Bonilla-Toribio, D. Buiza-Rueda, R. Pineda-Sánchez, F. Carrillo, P. Gómez-Garre, P. Mir (Seville, Spain)

    Objective: To identify genetic variants associated with different clinical responses in patients with Parkinson’s disease(PD) treated with opicapone. Background: Opicapone is a catechol‐O‐methyltransferase(COMT) inhibitor used…
  • 2023 International Congress

    Low Vision Occupational Therapy for Parkinson’s Disease – A Pilot Study at the University of Alabama at Birmingham

    C. Parker, M. Maher, J. Vice, L. Lieb, M. Dean (BIRMINGHAM, USA)

    Objective: Assess usefulness of low vision occupational therapy (OT) in a small cohort of Parkinson’s disease (PD) patients. Background: PD patients report vision-related symptoms more…
  • 2023 International Congress

    WATCH-PD: Longitudinal Digital Assessments in Early Parkinson’s Disease

    T. Kangarloo, ER. Dorsey, P. Auinger, D. Volfson, P. Padmanabhan, Y. Gong, B. Tracey, D. Stephenson, D. Anderson, J. Severson, M. Kostrzebski, P. Wilmot, Y. Pohlson, J. Cosman, J. Adams (Cambridge, USA)

    Objective: To provide a longitudinal profile of early Parkinson’s disease (PD) progression using clinical and digital measures, and to evaluate the extent to which digital…
  • 2023 International Congress

    Risk of hallucinations and amantadine treatment in levodopa-induced dyskinesia patients with Parkinson’s disease: a meta-analysis of randomized controlled trials

    M. Adil, T. Ahmad, M. Sharma (New Delhi, India)

    Objective: The present meta-analysis aims to find out association between risk of hallucinations and amantadine treatment in levodopa-induced dyskinesia (LID) patients with Parkinson’s disease (PD).…
  • 2023 International Congress

    modulation of sodium potassium ATPase activity by norepinepherine and serotonin to find an effective cure of parkinson’s disease by introducing the novel concept of insilico drug repurposing

    S. Sinha (Prayagraj, India)

    Objective: Parkinson's disease can cause neuropsychiatric disturbances which can range from mild to severe. This includes disorders of speech, cognition, mood, behaviour, and thought. In addition to…
  • 2023 International Congress

    Exercise and levodopa metabolism in Parkinson disease

    M. Figura, J. Giebułtowicz, A. Mrozowicz, S. Szlufik, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of our paper was to assess if standard physical exercise may change pharmacokinetics of levodopa/benserazide in patients with and without prior exposure…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley